Macrophages and Osteoclasts Stem from a Bipotent Progenitor Downstream of a Macrophage/osteoclast/dendritic Cell Progenitor

Overview

Journal Blood Adv

Specialty Hematology

Date 2018 Jan 4

PMID 29296846

Citations 21

Authors

Yanling Xiao

Jara Palomero

Joanna Grabowska

Liqin Wang

Iris de Rink

Luuk van Helvert

Jannie Borst

Affiliations

Soon will be listed here.

Abstract

Monocytes/macrophages (MΦs), osteoclasts (OCs), and dendritic cells (DCs) are closely related cell types of high clinical significance, but the exact steps in their lineage commitment are unclear. In studies on MΦ and DC development, OC development is generally not addressed. Furthermore, findings on DC development are confusing, because monocytes can also differentiate into DC-like cells. To resolve these issues, we have examined the development of monocytes/MΦs, OCs, and DCs from common progenitors, using the homeostatic driver cytokines macrophage colony-stimulating factor, RANK ligand (L), and Flt3L. In mouse bone marrow, B220CD11bc-Kitc-Fms cells could be dissected into a CD27Flt3 population that proved oligopotent for MΦ/OC/DC development (MODP) and a CD27Flt3 population that proved bipotent for MΦ/OC development (MOP). Developmental potential and relationship of MODP and downstream MOP populations are demonstrated by differentiation cultures, functional analysis of MΦ/OC/DC offspring, and genome-wide messenger RNA expression analysis. A common DC progenitor (CDP) has been described as committed to plasmacytoid and conventional DC development. However, the human CDP proved identical to the MODP population, whereas the mouse CDP largely overlapped with the MODP population and was accordingly oligopotent for MΦ, OC, and DC development. The CXCR1 MΦ/DC progenitor (MDP) population described in the mouse generated MΦs and OCs but not DCs. Thus, monocytes/MΦs, OCs, and DCs share a common progenitor that gives rise to a bipotent MΦ/OC progenitor, but a dedicated DC progenitor is currently undefined. The definition of these progenitor populations may serve diagnostics and interventions in diseases with pathogenic activity of MΦs, OCs, or DCs.

Citing Articles

Exploring the Role of Macrophages and Their Associated Structures in Rheumatoid Arthritis.

Tian X, Chen J, Hong Y, Cao Y, Xiao J, Zhu Y J Innate Immun. 2025; 17(1):95-111.

PMID: 39938504 PMC: 11820663. DOI: 10.1159/000543444.

Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL-RANK Interaction.

Liu T, Li J, Duan M, Wang Y, Jiang Z, Gan C J Cell Mol Med. 2024; 28(23):e70256.

PMID: 39636143 PMC: 11619157. DOI: 10.1111/jcmm.70256.

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.

Richert I, Berchard P, Abbes L, Novikov A, Chettab K, Vandermoeten A Cancers (Basel). 2023; 15(18).

PMID: 37760603 PMC: 10526955. DOI: 10.3390/cancers15184635.

Origin of Osteoclasts: Osteoclast Precursor Cells.

Tsai J, Kaneko K, Suh A, Bockman R, Park-Min K J Bone Metab. 2023; 30(2):127-140.

PMID: 37449346 PMC: 10346003. DOI: 10.11005/jbm.2023.30.2.127.

New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis.

Hascoet E, Blanchard F, Blin-Wakkach C, Guicheux J, Lesclous P, Cloitre A Bone Res. 2023; 11(1):26.

PMID: 37217496 PMC: 10203317. DOI: 10.1038/s41413-023-00257-w.

References

Rathinam C, Geffers R, Yucel R, Buer J, Welte K, Moroy T . The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity. 2005; 22(6):717-28. DOI: 10.1016/j.immuni.2005.04.007. View

Jacome-Galarza C, Lee S, Lorenzo J, Aguila H . Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res. 2012; 28(5):1203-13. PMC: 3625454. DOI: 10.1002/jbmr.1822. View

Doulatov S, Notta F, Laurenti E, Dick J . Hematopoiesis: a human perspective. Cell Stem Cell. 2012; 10(2):120-36. DOI: 10.1016/j.stem.2012.01.006. View

Dorner B, Dorner M, Zhou X, Opitz C, Mora A, Guttler S . Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells. Immunity. 2009; 31(5):823-33. DOI: 10.1016/j.immuni.2009.08.027. View

Liu K, Nussenzweig M . Origin and development of dendritic cells. Immunol Rev. 2010; 234(1):45-54. DOI: 10.1111/j.0105-2896.2009.00879.x. View

Ferron M, Boudiffa M, Arsenault M, Rached M, Pata M, Giroux S . Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans. Cell Metab. 2011; 14(4):466-77. PMC: 3204353. DOI: 10.1016/j.cmet.2011.08.013. View

Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K . Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med. 1999; 190(12):1741-54. PMC: 2195707. DOI: 10.1084/jem.190.12.1741. View

Xiao Y, Zijl S, Wang L, de Groot D, van Tol M, Lankester A . Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis. Stem Cell Reports. 2015; 4(6):984-94. PMC: 4471835. DOI: 10.1016/j.stemcr.2015.04.012. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

10.

Weissman I . How One Thing Led to Another. Annu Rev Immunol. 2016; 34:1-30. DOI: 10.1146/annurev-immunol-032414-112003. View

11.

Akashi K, Traver D, Miyamoto T, Weissman I . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-7. DOI: 10.1038/35004599. View

12.

Auffray C, Fogg D, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N . CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med. 2009; 206(3):595-606. PMC: 2699130. DOI: 10.1084/jem.20081385. View

13.

Takayanagi H . The role of NFAT in osteoclast formation. Ann N Y Acad Sci. 2007; 1116:227-37. DOI: 10.1196/annals.1402.071. View

14.

Lacey D, Timms E, Tan H, Kelley M, Dunstan C, Burgess T . Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93(2):165-76. DOI: 10.1016/s0092-8674(00)81569-x. View

15.

Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K . Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood. 2001; 98(8):2544-54. DOI: 10.1182/blood.v98.8.2544. View

16.

Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen C . Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell. 2005; 121(2):295-306. DOI: 10.1016/j.cell.2005.02.013. View

17.

Lampiasi N, Russo R, Zito F . The Alternative Faces of Macrophage Generate Osteoclasts. Biomed Res Int. 2016; 2016:9089610. PMC: 4761668. DOI: 10.1155/2016/9089610. View

18.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S . Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95(7):3597-602. PMC: 19881. DOI: 10.1073/pnas.95.7.3597. View

19.

Onai N, Ohteki T . Bipotent or Oligopotent? A macrophage and DC progenitor revisited. Immunity. 2014; 41(1):5-7. DOI: 10.1016/j.immuni.2014.07.004. View

20.

Mootha V, Lindgren C, Eriksson K, Subramanian A, Sihag S, Lehar J . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34(3):267-73. DOI: 10.1038/ng1180. View